Annual SG&A
$1.54B$64.36M+4.37%
Summary
- Current Value
- As of today, DVA annual SG&A is $1.54B, up +4.37% on
- Historical Performance
- DVA annual SG&A is up +28.70% over the past 3 years, and up +39.43% over the past 5 years
- All-Time High Comparison
- DVA annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- DVA annual SG&A is +13.51% above its 3-year low of $1.36B reached on an earlier date
- Sector Comparison
- DVA annual SG&A is higher than 97.63% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $1.54B | +4.4% | +28.7% | +39.4% | +189.4% | |
| Quarterly SG&A | $414.37M | +5.3% | +13.4% | +14.1% | +179.9% | |
| TTM SG&A | $7.18B | +370.5% | +452.8% | +487.5% | +1184.7% | |
| Price | $104.74 | -36.5% | +32.5% | -11.8% | +194.2% | |
| Annual Operating Expenses | $2.26B | +1.9% | +20.6% | +31.6% | +145.9% | |
| Annual Operating Profit | $1.95B | +22.1% | +10.4% | +11.3% | +107.9% | |
| Annual D&A | $723.86M | -2.9% | +6.3% | +17.7% | +216.1% | |
| Annual Revenue | $12.82B | +5.6% | +10.3% | +12.5% | +109.8% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.54B | at high | |
| 5Y | $1.54B | at high | |
| All | $1.54B | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.36B | N/A | +13.5% |
| 5Y | $1.20B | +28.7% | |
| All | $11.50M | >+9999.0% |
SG&A History
FAQ
What is the current annual SG&A of DVA?
As of today, DVA annual SG&A is $1.54B
What is 1-year change in DVA annual SG&A?
DVA annual SG&A is up +4.37% year-over-year
What is 3-year change in DVA annual SG&A?
DVA annual SG&A is up +28.70% over the past 3 years
How far is DVA annual SG&A from its all-time high?
DVA annual SG&A is currently at its all-time high
How does DVA annual SG&A rank versus sector peers?
DVA annual SG&A is higher than 97.63% of companies in Healthcare sector
When is DVA next annual earnings release?
The next annual earnings release for DVA is on
Quarterly SG&A
$414.37M$1.57M+0.38%
Summary
- Current Value
- As of today, DVA quarterly SG&A is $414.37M, up +0.38% on
- Historical Performance
- DVA quarterly SG&A is up +5.30% year-over-year, and up +13.39% over the past 3 years
- All-Time High Comparison
- DVA quarterly SG&A is currently -0.03% below its historical high of $414.48M set on
- 3-Year Low Comparison
- DVA quarterly SG&A is +24.96% above its 3-year low of $331.61M reached on
- Sector Comparison
- DVA quarterly SG&A is higher than 96.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $414.37M | +0.4% | +5.3% | +13.4% | +14.1% | |
| Annual SG&A | $1.54B | – | +4.4% | +28.7% | +39.4% | |
| TTM SG&A | $7.18B | +349.9% | +370.5% | +452.8% | +487.5% | |
| Price | $104.74 | -16.4% | -36.5% | +32.5% | -11.8% | |
| Quarterly Operating Expenses | $414.37M | +0.4% | +5.3% | +13.4% | +14.1% | |
| Quarterly Operating Profit | $495.61M | -6.6% | -6.7% | +63.4% | +14.7% | |
| Quarterly D&A | $177.49M | +1.6% | -5.1% | -8.7% | +13.1% | |
| Quarterly Revenue | $3.42B | +1.2% | +4.8% | +16.0% | +17.0% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $414.48M | N/A | -0.0% |
| 3Y | $414.48M | -0.0% | |
| 5Y | $414.48M | -0.0% | |
| All | $414.48M | -0.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $374.09M | +10.8% | |
| 3Y | $331.61M | +25.0% | |
| 5Y | $281.43M | +47.2% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of DVA?
As of today, DVA quarterly SG&A is $414.37M
What is DVA quarterly SG&A most recent change?
DVA quarterly SG&A was up +0.38% on September 30, 2025
What is 1-year change in DVA quarterly SG&A?
DVA quarterly SG&A is up +5.30% year-over-year
How far is DVA quarterly SG&A from its all-time high?
DVA quarterly SG&A is currently -0.03% below its historical high of $414.48M set on December 31, 2024
How does DVA quarterly SG&A rank versus sector peers?
DVA quarterly SG&A is higher than 96.16% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
TTM SG&A
$7.18B$771.92M+12.05%
Summary
- Current Value
- As of today, DVA TTM SG&A is $7.18B, up +12.05% on
- Historical Performance
- DVA TTM SG&A is up +370.47% year-over-year, and up +452.78% over the past 3 years
- All-Time High Comparison
- DVA TTM SG&A is currently -60.99% below its historical high of $18.40B set on an earlier date
- 3-Year Low Comparison
- DVA TTM SG&A is +335.29% above its 3-year low of $1.65B reached on an earlier date
- Sector Comparison
- DVA TTM SG&A is higher than 93.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $7.18B | +349.9% | +370.5% | +452.8% | +487.5% | |
| Annual SG&A | $1.54B | – | +4.4% | +28.7% | +39.4% | |
| Quarterly SG&A | $414.37M | +0.4% | +5.3% | +13.4% | +14.1% | |
| Price | $104.74 | -16.4% | -36.5% | +32.5% | -11.8% | |
| TTM Operating Profit | $1.94B | -1.8% | +2.9% | +34.3% | +10.1% | |
| TTM D&A | $702.75M | -1.3% | -5.7% | -1.5% | +12.0% | |
| TTM Revenue | $13.32B | +1.2% | +5.1% | +14.4% | +15.4% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.18B | N/A | at high |
| 3Y | $7.18B | N/A | at high |
| 5Y | $7.18B | N/A | at high |
| All | $18.40B | N/A | -61.0% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.71B | N/A | +52.4% |
| 3Y | $1.65B | N/A | +335.3% |
| 5Y | $1.65B | N/A | +335.3% |
| All | -$388.68M | N/A | +1946.3% |
TTM SG&A History
FAQ
What is the current TTM SG&A of DVA?
As of today, DVA TTM SG&A is $7.18B
What is DVA TTM SG&A most recent change?
DVA TTM SG&A was up +12.05% on September 30, 2025
What is 1-year change in DVA TTM SG&A?
DVA TTM SG&A is up +370.47% year-over-year
How does DVA TTM SG&A rank versus sector peers?
DVA TTM SG&A is higher than 93.69% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/927066/000092706625000165/0000927066-25-000165-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706625000012/0000927066-25-000012-index.htm
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva